The Missouri Department of Social Services proposed to amend regulations under 13 CSR 70-20 to remove outdated provisions regarding the return of unused prescription drugs issued to a MO HealthNet (Medicaid) participant. Comments are due July 31, 2021.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Board of Pharmacy issued a reminder that the Board of Nursing has a rule that requires the name of the supervising physician to be on the prescription from nurse practitioners.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy published its July 2021 Newsletter. Highlights include information from the PDMP Director with recommendations to follow if a prescription is suspected of being fraudulent and with information to access Nebraska data. Please recall that the board announced on April 14 that interstate data sharing was established with Nebraska.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Department of Health and Human Services (HHSC) announced its submission of an extension application to the Centers for Medicare & Medicaid Services (CMS) for the Texas Healthcare Transformation Quality Improvement Program (THTQIP) waiver under section 1115 of the Social Security Act. The extension request is for approximately 10 years, and reflects the same terms and conditions agreed to and approved by CMS on Jan. 15, 2021. It will allow Texas to continue flexibility to pursue the goals of the existing 1115 waiver:
For more information, contact NACDS’ Mary Staples at 817-442-1155.
After 16 months under a declared state of emergency due to the COVID-19 pandemic, on July 8th Gov. Jared Polis (D) ended all emergency orders connected with the pandemic.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
On July 13 Governor John Carney (D) ended the state Public Health Emergency and all Executive Orders. On July 12, the Governor issued a new Executive Order authorizing pharmacists, pharmacy technicians and interns to administer COVID testing and vaccinations.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
The Drug Enforcement Administration (DEA) Ohama Field Division is conducting a series of Lunch and Learn sessions related to fraud and abuse associated with promethazine with codeine. Details are available in the flyer that includes link to register. For more information, contact the DEA Diversion Outreach Coordinator Erin Payne.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Effective July 1, 2021, the state adopted a single Louisiana Medicaid Single PDL – Fee for Service and Managed Care Organizations . The Preferred Drug List (PDL)/Non-Preferred Drug List (NPDL) is a list of over 100 therapeutic classes reviewed by the Pharmaceutical & Therapeutics (P&T) Committee.
Also in Louisiana, the Board of Pharmacy Regulation Revision Committee will be meeting in Baton Rouge on August 3rd to numerous proposed draft rules found here – http://www.pharmacy.la.gov/assets/docs/Cmtes/RegRev/Agenda_2021-0803.pdf
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Office of Pharmacy Services has issued an advisory to notify pharmacies that the Medicaid Fee-for-Service (FFS) Program Pharmacy Services call center helpline is returned to live call operations on July 14. If you are interested in directly receiving upcoming advisories, please forward your name, company affiliation and email address directly to: Deborah.washington@maryland.gov
For more information, contact NACDS’ Jill McCormack at 717-592-8977.